Bruised by its failure to enter the superlatively lucrative market for coronavirus shots, British drug developer GlaxoSmithKline (LSE: GSK) is to spend billions 31 May 2022
Building on a licensing deal with AstraZeneca, British biotech RQ Bio has announced its launch, with a focus on developing antibody treatments and preventive th 17 May 2022
Investment company eureKARE, which is focused on financing and building biotech companies in the disruptive fields of synthetic biology and the microbiome, has 12 May 2022
UK biotech Forcefield Therapeutics has launched to develop drugs to protect heart function by arresting the loss of cardiomyocytes following myocardial infarcti 25 April 2022
At the same time as announcing strategic financing agreements worth $260 million, USA-based BioXcel Therapeutics has announced the formation of wholly-owned sub 20 April 2022
USA-based Insmed (NASDAQ CM: INSM) is a biopharmaceutical company on the development and commercialization of novel, targeted inhaled therapies for patients with serious rare diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news